About Farapulse
Farapulse is a company based in Menlo Park (United States) founded in 2014.. Farapulse has raised $36.3 million across 6 funding rounds from investors including Boston Scientific, European Union and F-Prime Capital. Farapulse offers products and services including FARAPULSE PFA System. Farapulse operates in a competitive market with competitors including Kardium, Argá Medtech, Adagio Medical, Affera and Field Medical, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Boston Scientific Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$36.3 M (USD)
in 6 rounds
-
Latest Funding Round
$2.14 M (USD), Grant
Mar 01, 2021
-
Investors
Boston Scientific
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Farapulse
Farapulse offers a comprehensive portfolio of products and services, including FARAPULSE PFA System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Uses electrical pulses to treat atrial fibrillation by isolating pulmonary veins safely.
Funding Insights of Farapulse
Farapulse has successfully raised a total of $36.3M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $2.14 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $2.1M
-
First Round
First Round
(13 Oct 2015)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Grant - Farapulse | Valuation |
investors |
|
| Sep, 2020 | Amount | Series C - Farapulse | Valuation | Boston Scientific |
|
| May, 2018 | Amount | Series B - Farapulse | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Farapulse
Farapulse has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Boston Scientific, European Union and F-Prime Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location | |
|
Wide range of medical devices
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Farapulse
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Farapulse
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Farapulse Comparisons
Competitors of Farapulse
Farapulse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kardium, Argá Medtech, Adagio Medical, Affera and Field Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Atrial fibrillation ablation devices are developed by Kardium.
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac arrhythmias are developed by Argá Medtech.
|
|
| domain | founded_year | HQ Location |
Cardiovascular therapies are developed by Adagio Medical in stealth mode.
|
|
| domain | founded_year | HQ Location |
Devices for treating heart rhythm disorders are developed.
|
|
| domain | founded_year | HQ Location |
Pulsed electric field ablation devices for heart arrhythmias are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Farapulse
Frequently Asked Questions about Farapulse
When was Farapulse founded?
Farapulse was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Farapulse located?
Farapulse is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Farapulse a funded company?
Farapulse is a funded company, having raised a total of $36.3M across 6 funding rounds to date. The company's 1st funding round was a Series B of $12M, raised on Oct 13, 2015.
What does Farapulse do?
Farapulse was founded in 2014 and is based in Menlo Park, United States. Operations focus on the medical device sector, specifically cardiac ablation using pulsed field ablation techniques. The flagship product, ENDO FARAWAVE, consists of a percutaneous catheter designed to produce transmural and contiguous lesions on the endocardium. Another device, EPI FARAONE, is intended for creating lesions around pulmonary veins.
Who are the top competitors of Farapulse?
Farapulse's top competitors include Kardium, Adagio Medical and Field Medical.
What products or services does Farapulse offer?
Farapulse offers FARAPULSE PFA System.
Who are Farapulse's investors?
Farapulse has 3 investors. Key investors include Boston Scientific, European Union, and F-Prime Capital.